Cargando…

COVID-19 and corporate tax avoidance: International evidence()

Governments across the globe initiated various tax reforms in the post- Global Financial Crisis period to rein in aggressive corporate tax avoidance for managing budget deficits. These developments created new realities in the international business environment by altering the costs and benefits of...

Descripción completa

Detalles Bibliográficos
Autores principales: Athira, A., Ramesh, Vishnu K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10198770/
https://www.ncbi.nlm.nih.gov/pubmed/37235071
http://dx.doi.org/10.1016/j.ibusrev.2023.102143
_version_ 1785044805955354624
author Athira, A.
Ramesh, Vishnu K.
author_facet Athira, A.
Ramesh, Vishnu K.
author_sort Athira, A.
collection PubMed
description Governments across the globe initiated various tax reforms in the post- Global Financial Crisis period to rein in aggressive corporate tax avoidance for managing budget deficits. These developments created new realities in the international business environment by altering the costs and benefits of corporate tax management. Yet, we have a limited understanding of the effectiveness of tax reforms in controlling corporate tax avoidance at the global level. COVID-19 offers a litmus test for how corporates manage their taxes during the pandemic in light of past tax reforms. We use financial constraints and reputational costs as two contradicting theoretical perspectives to explain corporate tax avoidance during the crisis. Consistent with the financial constraints hypothesis, we find that firms avoid taxes amid COVID-19 to prevent liquidity crunches. Our study also highlights the role of country-level information and governance quality in curbing tax avoidance during extreme events like COVID-19. Our findings call for an immediate tax policy intervention to limit corporate tax avoidance during the ongoing pandemic phases.
format Online
Article
Text
id pubmed-10198770
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Elsevier Ltd.
record_format MEDLINE/PubMed
spelling pubmed-101987702023-05-22 COVID-19 and corporate tax avoidance: International evidence() Athira, A. Ramesh, Vishnu K. Int Bus Rev Article Governments across the globe initiated various tax reforms in the post- Global Financial Crisis period to rein in aggressive corporate tax avoidance for managing budget deficits. These developments created new realities in the international business environment by altering the costs and benefits of corporate tax management. Yet, we have a limited understanding of the effectiveness of tax reforms in controlling corporate tax avoidance at the global level. COVID-19 offers a litmus test for how corporates manage their taxes during the pandemic in light of past tax reforms. We use financial constraints and reputational costs as two contradicting theoretical perspectives to explain corporate tax avoidance during the crisis. Consistent with the financial constraints hypothesis, we find that firms avoid taxes amid COVID-19 to prevent liquidity crunches. Our study also highlights the role of country-level information and governance quality in curbing tax avoidance during extreme events like COVID-19. Our findings call for an immediate tax policy intervention to limit corporate tax avoidance during the ongoing pandemic phases. Elsevier Ltd. 2023-08 2023-05-09 /pmc/articles/PMC10198770/ /pubmed/37235071 http://dx.doi.org/10.1016/j.ibusrev.2023.102143 Text en © 2023 Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Athira, A.
Ramesh, Vishnu K.
COVID-19 and corporate tax avoidance: International evidence()
title COVID-19 and corporate tax avoidance: International evidence()
title_full COVID-19 and corporate tax avoidance: International evidence()
title_fullStr COVID-19 and corporate tax avoidance: International evidence()
title_full_unstemmed COVID-19 and corporate tax avoidance: International evidence()
title_short COVID-19 and corporate tax avoidance: International evidence()
title_sort covid-19 and corporate tax avoidance: international evidence()
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10198770/
https://www.ncbi.nlm.nih.gov/pubmed/37235071
http://dx.doi.org/10.1016/j.ibusrev.2023.102143
work_keys_str_mv AT athiraa covid19andcorporatetaxavoidanceinternationalevidence
AT rameshvishnuk covid19andcorporatetaxavoidanceinternationalevidence